Objectives

This symposium aims to provide an update on the current knowledge of NASH and to inform you on the exciting developments in the field. It is expected that in 2021 the first approved drug for NASH will enter the market. Several well known experts in the field will present the most recent developments. Moreover, a collaboration platform (NASH Clinical Network) will be presented. This meeting is also intended to facilitate collaborations between participants and to provide a momentum to network and meet colleagues working in the field of NASH. It is the intention of the organizers to increase awareness of this growing problem and to expand current knowledge.

Audience

Gastroenterologists, Diabetologists, Endocrinologists, Obesity specialists, Hepatologists, Vascular specialists and pharmaceutical industry.

Registration

Accreditation for gastroenterologists and internists will be requested. Only a limited number of participants will be admitted. Electronic registration sending an email is a prerequisite. Send to: internesecretariaat@franciscus.nl. Registration fee: 25 euro. Transfer to Stichting O&O Interne Specialismen Franciscus Gasthuis account no NL 07ABNA 0552169927. We look forward to see you in Rotterdam.